Pfizer PFE Revenue Breakdown

NYSE PFE
$27.54 -0.52 (-1.85%)
At close: Nov 19, 2026 · 4:01 PM EST
Quarterly revenue breakdowns for Pfizer, quarters ended Mar 2010 to Sep 2026, as reported in its filings.
Quarterly history

Pfizer Quarterly Revenue by Products & Services

Quarters Mar 2010–Sep 2026
Lines 37
Sep 2026 Total $16.28B

Eliquis was Pfizer’s largest revenue line in the Sep 2026 quarter, bringing in $2.52B of $16.28B (15%).

Pfizer revenue by products and services, quarters ended Mar 2010 to Sep 2026
Products and Services Mar 2010 Jun 2010 Sep 2010 Mar 2011 Mar 2011 Jun 2011 Sep 2011 Dec 2011 Mar 2012 Jun 2012 Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Dec 2018 Dec 2019 Sep 2024 Mar 2025 Sep 2026
Eliquis $2.52B
Prevnar Family $1.56B
Vyndaqel Family $1.77B
Paxlovid $449.00M
Ibrance $1.08B
Comirnaty $808.00M
All Other Hospital & Biosimilars $928.00M
All Other Primary Care $674.00M
Xtandi $541.00M
Padcev $720.00M
All Other Specialty Care $503.00M
All Other Oncology $341.00M
Nurtec Odt/Vydura $547.00M
Oncology Biosimilars $378.00M
Lorbrena $387.00M
Abrysvo $303.00M
Adcetris $231.00M
Inlyta $232.00M
Xeljanz $213.00M
Braftovi/Mektovi $244.00M
Zavicefta (Outside The U.S. & Canada) $179.00M
Inflectra $186.00M
Enbrel (Outside The U.S. & Canada) $151.00M
Octagam $134.00M
Sulperazon (Outside The U.S. & Canada) $96.00M
Bosulif $71.00M
Tukysa $142.00M
Orgovyx $153.00M
Genotropin $94.00M
Cresemba $100.00M
Zithromax $47.00M
Benefix $102.00M
Fsme-Immun/Ticovac $104.00M
Cibinqo $101.00M
Elrexfio $83.00M
Talzenna $59.00M
Tivdak $39.00M
Total $16.28B
Totals include 17 discontinued lines from earlier reporting.
Quarterly history

Pfizer Quarterly Revenue by Segment

Quarters Jun 2010–Sep 2026
Lines 2
Sep 2026 Total $16.58B

Biopharma was Pfizer’s largest segment in the Sep 2026 quarter, bringing in $16.28B of $16.58B (98%).

Pfizer revenue by segment, quarters ended Jun 2010 to Sep 2026
Segment Jun 2010 Sep 2010 Mar 2011 Mar 2011 Jun 2011 Sep 2011 Dec 2011 Mar 2012 Jun 2012 Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Mar 2014 Jun 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Biopharma $17.14B $14.16B $14.66B $16.28B
Other Business Activities $414.00M $289.00M $373.00M $300.00M
Total $17.56B $14.45B $15.03B $16.58B
Totals include 18 discontinued lines from earlier reporting.
Quarterly history

Pfizer Quarterly Revenue by Reporting Unit

Quarters Mar 2018–Sep 2026
Lines 4
Sep 2026 Total $16.28B

Primary Care was Pfizer’s largest revenue line in the Sep 2026 quarter, bringing in $6.97B of $16.28B (43%).

Pfizer revenue by reporting unit, quarters ended Mar 2018 to Sep 2026
Reporting Unit Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Mar 2021 Jun 2021 Sep 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Sep 2024 Dec 2024 Mar 2025 Sep 2026
Primary Care $6.97B
Specialty Care $3.35B
Oncology $4.33B
Hospital & Biosimilars $1.64B
Total $16.28B
Totals include 11 discontinued lines from earlier reporting.

Pfizer Revenue Breakdown API

Pull Pfizer's revenue breakdown - every line it reports, for every period - into your own models, spreadsheets and apps with the Business Quant Segments API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/segments?series=Revenue&ticker=PFE&dimension=Quarter&api_key=YOUR_API_KEY